MEGGLE returning to ‘live’ CPHI in Frankfurt

Wasserburg, Germany: – Pharmaceutical lactose specialist MEGGLE will once again be a prominent presence at the CPHI worldwide pharma expo, when it exhibits at the rebranded event in Frankfurt.

MEGGLE is one of CPhI’s most established exhibitors, having attended every Worldwide expo for more than 20 years, almost since the event was initially founded in 1991.

Array of excipients

The MEGGLE stand at Booth 80F95 in the Excipients Zone in Hall 8.0 of the Frankfurt Messe exhibition complex will display its extensive range of lactose-based and co-processed excipients precisely tailored to a wide range of pharmaceutical applications.

Applications featured will include tableting, capsule and sachet filling, dry powder inhalation and continuous manufacturing processes.

Once again, the MEGGLE stand will offer a family atmosphere with good hospitality, latest news about MEGGLE, and comfortable places to meet its experts in Sales, Application Technology and R&D.

Return to CPHI

Christoph Adler, Head of Marketing & Area Manager for Business Unit Excipients, will be part of the MEGGLE event team.

“We are very much looking forward to being able to return to CPHI as a physical event, to welcome all our customers and distribution partners in our home country Germany.” said Mr. Adler.

About MEGGLE

Bavarian-based MEGGLE is one of the world’s experts in co-processing and powder technology. From its roots as a dairy operation in the late 1880’s, MEGGLE has become one of the world’s leading manufacturers of pharmaceutical lactose, supplying the pharma market segment with a broad-based and unique lactose product portfolio.

MEGGLE Business Unit Excipients has harnessed outstanding product quality and intelligent innovation to become a global leader in the manufacture of lactose-based excipients, focusing on products for direct tableting and dry powder inhalation.

A multidisciplinary team of committed and highly qualified people allows MEGGLE clients to benefit from pioneering experience and innovative drive in industrial milk and whey processing. The company constantly strives to develop high-tech, functional products for solid dosage forms and DPI applications, where they can deliver maximum performance.

The company has introduced several pioneering products, notably Tablettose®, the world’s first agglomerated lactose for direct tableting, Cellactose® 80, a pioneering co-processed excipient based on cellulose-lactose for outstanding compression and flow properties and RetaLac®, the first direct compression co-processed excipient using a hypromellose-lactose base for sustained release formulations.

To learn more, visit: https://www.meggle-pharma.com/en/home.html

About CPHI Frankfurt 2022

In its 33rd year, CPhI Worldwide is rebranding as CPHI ‘At the heart of Pharma’, which will continue to be the flagship European annual trade show for pharma ingredients and partner sourcing.

CPHI Frankfurt adopts a hybrid model fusing a large physical expo with an online dimension to make networking and browsing easier and to extend the time frame of the event indefinitely.

For 2022, CPHI Frankfurt is a three-day physical event opening November 1 at the Messe expo center in Frankfurt-am-Main, with the online exhibition opening from September 28.

The previous ‘seven shows in one’ format has been replaced by a larger number of more precisely targeted exhibition zones and online spaces, including Analytical & Lab Zone, APIs, BioProduction, CRO & Clinical Trials, Excipients, Fine Chemicals, Finished Dosage Formulations, ICSE (Outsourcing), InnoPack (Packaging), Integrated Pharma, Natural Extracts, and PMEC (Machinery and Equipment.

CPHI Frankfurt is organised by Informa Markets with further information at: https://www.cphi.com/europe/en/home.html

Resources

Click on MEGGLE at CPHI Frankfurt 2022  to view event profile.